TCON
TRACON Pharmaceuticals, Inc. Common Stock
TCON
TCON
Delisted
TCON was delisted on the 27th of June, 2024.
18 hedge funds and large institutions have $2.14M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Holders
18
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$136K | |
| 2 | +$61K | |
| 3 | +$57K | |
| 4 |
Millennium Management
New York
|
+$48K |
| 5 |
DY
Dowling & Yahnke
San Diego,
California
|
+$26K |
Top Sellers
| 1 | -$102K | |
| 2 | -$99.2K | |
| 3 | -$38K | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$25K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3.94K |